NCT00204347View on ClinicalTrials.gov

Effective Measurement of Risperidone Treatment Outcome for Persons With Borderline Personality Disorder

PHASE4CompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

July 31, 2003

Primary Completion Date

October 31, 2007

Study Completion Date

October 31, 2007

Conditions
Borderline Personality Disorder
Interventions
DRUG

risperidone

Trial Locations (1)

35205

University of Alabama at Birmingham, Birmingham

Sponsors

Collaborators (1)

Janssen Pharmaceutica
All Listed Sponsors
collaborator

Janssen Pharmaceutica

INDUSTRY

lead

University of Alabama at Birmingham

OTHER